Access EIS investments for July 2023.

Syndicate Room

3 August 2023•2 min read

In July we added one new startup to the Access portfolio, co-investing alongside one of our angel investors (for more on our super angels and our co-investment model, see our [dedicated page](/invest/angel-investors)). Read on for more about our latest investments. If you would like to receive this update each month, [sign up for our newsletter here](/subscribe). ### Isosconnect Isosconnect have created a platform that optimises fundamental clinical processes, caters for safe online consultations and offers the opportunity for peer-to-peer work between modalities and specialties to create a digital home for independent health and wellbeing practitioners. [

](https://www.isosconnect.com/) **Pre/post revenue:** Post-revenue. **Angel:** Our angel partner in the round has a weighted IRR of 25% and has invested in Current Health, Huma and ClearBank, amongst others. **Total Round:** approx. £800,000 [Visit website](https://www.isosconnect.com/) If you’re interested in the Access EIS Fund and would like to find out the benefits of investing, you can call us on 01223 478 558 and we'll be happy to answer any questions you might have. Or, if you're ready to make an investment, click the button below:

What is Access EIS?

Read our fund brochure for everything you need to know about the Access EIS Fund, from the specifics of our innovative co-investment model to our fees, and how to invest.

Risk warning: Please click here to read the full risk warning.

Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.

This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021).

We use cookies to improve our service. By continuing to use this site you are agreeing to their use. Find out more.